262 results on '"Richards, A.M."'
Search Results
2. Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study
3. Genetic markers of repolarization and arrhythmic events after acute coronary syndromes
4. Cardiac Natriuretic Peptides
5. List of Contributors
6. Regional vascular response to ProAngiotensin-12 (PA12) through the rat arterial system
7. Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis
8. Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure
9. Prognostic value of sST2 in heart failure patients with diabetes
10. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury
11. Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
12. Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model
13. Changes in Estimated Glomerular Filtration Rate and Prognostication Using 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Equations Incorporating Cystatin C
14. Cardiovascular effects of native and non-native urotensin II and urotensin II-related peptide on rat and salmon hearts
15. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts 2-Year Cardiovascular Events in Patients After Acute Chest Pain
16. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts Mortality in Patients With Acute Chest Pain
17. Identifying Candidate Protein Markers of Acute Kidney Injury in Acute Decompensated Heart Failure
18. Prognostic Performance of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Predicting Mortality in Asian and Western Patients With Acute Breathlessness
19. Chronic obstructive pulmonary disease in heart failure: influence on circulating biomarkers and outcome
20. Prognostic performance of soluble urokinase plasminogen activator receptor for 1-year mortality in Asian and Western patients with acute breathlessness
21. Soluble urokinase plasminogen activator receptor (suPAR) can predict long-term mortality in patients with acute chest pain
22. The relationship between glycosylation of proBNP at threonine 71, BNP, BNP1–32 and obesity in patients with heart failure
23. Sex differences in ventricular remodeling and long-term heart failure outcomes following acute coronary syndrome
24. Soluble urokinase plasminogen activator receptor (suPAR) predicts 2-year cardiovascular events in patients after acute chest pain
25. Age-related differences in ventricular remodeling and long-term heart failure outcomes following acute coronary syndrome
26. Prognostic value of NT-proBNP and best cut-offs for risk prediction in obese patients with chronic systolic heart failure
27. Transcriptomic responses associated with kidney injury and repair in acute decompensated heart failure
28. Systemic mesenchymal stem cell-derived exosomes reduce myocardial infarct size: characterization with MRI in a porcine model
29. Atrial fibrillation and the prognostic performance of biomarkers in heart failure
30. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events A GENIUS-CHD Study of Individual Participant Data
31. A clinical and biochemical score for mortality prediction in patients with acute dyspnoea: derivation, validation and incorporation into a bedside programme
32. Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure
33. Natriuretic peptide responses to acute and chronic ventricular pacing in sheep
34. Dynamic external fixation for complex intraarticular phalangeal fractures
35. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men
36. Central angiotensin II AT1-receptor antagonism in normal and heart-failed sheep
37. Effect of ouabain on pressor responsiveness in normal man
38. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men
39. Cardiovascular actions of ANF: contributions of renal, neurohumoral, and hemodynamic factors in sheep
40. A017 Cardiac Biomarkers to Guide Risk in Secondary Prevention Post-Acute Coronary Syndromes
41. A055 Sex Differences in Ventricular Remodeling and Long-Term Heart Failure Outcomes Following Acute Coronary Syndrome
42. A051 Long-term Outcomes for Patients with Heart Failure in New Zealand according to Ejection Fraction Phenotype
43. A054 Age-Related Differences in Ventricular Remodeling and Long-Term Heart Failure Outcomes Following Acute Coronary Syndrome
44. Low Mir-19B-1-5P Expression In Acs Patients Is Related To Aspirin Resistance And Major Adverse Cardio-Cerebrovascular Event (Macce)
45. Sleep Study-Guided Multidisciplinary Therapy for Acute Coronary Syndrome: A Randomized Clinical Trial
46. Subsequent Event Risk in Individuals With Established Coronary Heart Disease
47. Identification of Amino-Terminal Pro-C-Type Natriuretic Peptide in Human Plasma
48. Chapter 1 - Cardiac Natriuretic Peptides
49. Laurin-Sandrow syndrome—a surgical challenge
50. Effectiveness of EDACS Versus ADAPT Accelerated Diagnostic Pathways for Chest Pain: A Pragmatic Randomized Controlled Trial Embedded Within Practice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.